Publications – CRICS-TRIGGERSEP

2025

Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically ill patients with solid organ transplant: a retrospective multicenter study.

Vaidie J, Demiselle J, Gabriel A, Guillon A, Peju E, Pène F, et al.

Intensive Care Med. 2025 Aug;51(8):1442-1452. Epub 2025 Jul 16.

DOI : 10.1007/s00134-025-08024-7 PMID : 40668232

Consulter la publication

2025

Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock.

Vignon P, Charron C, Legras A, Musset F, Slama M, Prat G, et al.

Intensive Care Med. 2025 Jan;51(1):94-105. Epub 2025 Jan 7.

DOI : 10.1007/s00134-024-07748-2 PMID : 39774865

Consulter la publication

2024

Management of hematological patients requiring emergency chemotherapy in the intensive care unit.

Lafarge A, Chean D, Whiting L, Clere-Jehl R; Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH); Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP).

Intensive Care Med. 2024 Jun;50(6):849-860. Epub 2024 May 15. Review.

DOI : 10.1007/s00134-024-07454-z PMID : 38748265

Consulter la publication

2024

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.

Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, et al.

Lancet Respir Med. 2024 May;12(5):366-374. Epub 2024 Feb 1.

DOI : 10.1016/S2213-2600(23)00430-7 PMID : 38310918

Consulter la publication

2023

Inhaled amikacin to prevent ventilator-associated pneumonia.

Ehrmann S, Barbier F, Demiselle J, Quenot JP, Herbrecht JE, Roux D, et al.

N Engl J Med. 2023 Nov 30;389(22):2052-2062. Epub 2023 Oct 25.

DOI : 10.1056/NEJMoa2310307 PMID : 37888914

Consulter la publication

2023

Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.

Declercq PL, Fournel I, Demeyere M, Berraies A, Ksiazek E, Nyunga M, et al.

Intensive Care Med. 2023 Nov;49(11):1438-1439.

DOI : 10.1007/s00134-023-07217-2 PMID : 37755457

Consulter la publication

2023

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al.

Lancet Respir Med. 2023 Oct;11(10):894-904. Epub 2023 May 31.

DOI : 10.1016/S2213-2600(23)00158-3 PMID : 37269870

Consulter la publication

2023

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).

Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, et al.

Lancet Respir Med. 2023 Jul;11(7):602-612. Epub 2023 Mar 20.

DOI : 10.1016/S2213-2600(23)00092-9 PMID : 36958363

Consulter la publication

2023

Hydrocortisone in severe community-acquired pneumonia.

Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al.

N Engl J Med. 2023 May 25;388(21):1931-1941. Epub 2023 Mar 21.

DOI : 10.1056/NEJMoa2215145 PMID : 36942789

Consulter la publication

2022

Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial.

Frat JP, Quenot JP, Badie J, Coudroy R, Guitton C, Ehrmann S, et al.

JAMA. 2022 Sep 27;328(12):1212-1222.

DOI : 10.1001/jama.2022.15613 PMID : 36166027

Consulter la publication

2022

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.

Coudroy R, Frat JP, Ehrmann S, Pène F, Decavèle M, Terzi N, et al.

Lancet Respir Med. 2022 Jul;10(7):641-649. Epub 2022 Mar 21.

DOI : 10.1016/S2213-2600(22)00096-0 PMID : 35325620

Consulter la publication

2022

Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: a post hoc analysis of the NUTRIREA2 trial.

Piton G, Le Gouge A, Boisramé-Helms J, Anguel N, Argaud L, Asfar P, et al.

Intensive Care Med. 2022 Apr;48(4):458-466. Epub 2022 Feb 22.

DOI : 10.1007/s00134-022-06637-w PMID : 35190840

Consulter la publication

2021

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label metatrial.

Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, et al.

Lancet Respir Med. 2021 Dec;9(12):1387-1395. Epub 2021 Aug 20.

DOI : 10.1016/S2213-2600(21)00356-8 PMID : 34425070

Consulter la publication

Nos publications sont le reflet de nos collaborations

Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically ill patients with solid organ transplant: a retrospective multicenter study.

Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock.

Management of hematological patients requiring emergency chemotherapy in the intensive care unit.

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.

Inhaled amikacin to prevent ventilator-associated pneumonia.

Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).

Hydrocortisone in severe community-acquired pneumonia.

Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial.

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.

Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: a post hoc analysis of the NUTRIREA2 trial.

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label metatrial.